| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Zivo Bioscience, Inc.
13D/A
ZIVO · 98978N101
|
12.2% |
1/7/2025
Event 12/26/2024
|
||||
| Mark E. Strome | 12.2% | |||||
| Strome Group, Inc. | 6.1% | |||||
| Strome Investment Management, LP | 6.1% | |||||
| Strome Mezzanine Fund, LP | 1.2% | |||||
| Strome Mezzanine Fund II, LP | 4.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.